ARCHIVES

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 44 | November 17, 1989

Download PDF Visit The Full Archive

Related Articles

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.

June 23, 2000

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012